Biosyent Inc (TSE:RX) has released an update.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
BioSyent Inc., a specialty pharmaceutical company listed on the TSX Venture Exchange, has granted 66,020 Restricted Share Units to its directors, officers, and employees under the RSU Plan, set to fully vest on the third anniversary of the grant date. The company focuses on acquiring and marketing innovative products that contribute to patient care, supported by a team of healthcare professionals.
For further insights into TSE:RX stock, check out TipRanks’ Stock Analysis page.